Skip to main content
WeightCited

Omega-3 pour Metabolic Syndrome

B Preuves Au moins un essai randomisé le soutient, avec des résultats globalement concordants.

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

B

En conclusion

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label
Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …
Dose: Mediterranean diet vs: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome

Population: Patients with psoriatic arthritis

Randomized Controlled Trial n=45 16 weeks
Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.
Dose: 4 g/day P-OM3 vs: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles

Population: MetSyn patients vs healthy controls

Key Statistics

44

Études

3000

Participants

↑

Positive

B

Note

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
250-500 mg EPA+DHA/day
antiinflammatory:
2,000-4,000 mg/day
weightmanagement:
1,000-3,000 mg EPA+DHA/day

Limite supérieure : 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Posologies étudiées dans la recherche

Posologie Durée Effet N
Mediterranean diet 12 weeks Positive --
4 g/day P-OM3 16 weeks Positive 45

Moment optimal de prise : With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

Effets indésirables signalés

  • ⚠ Fishy aftertaste
  • ⚠ GI discomfort
  • ⚠ Increased bleeding time (at high doses)
  • ⚠ Nausea

Interactions connues

  • ● Blood thinners (may enhance anticoagulant effect at high doses)
  • ● Blood pressure medications (additive effect)
  • ● Orlistat (reduced absorption)

Apport maximal tolérable : 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Omega-3 help with Metabolic Syndrome?
Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).
How much Omega-3 should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3?
Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 and Metabolic Syndrome?
We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

Autres ingrédients pour Metabolic Syndrome

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

References

  1. [1] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
  2. [2] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
  3. [3] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
  4. [4] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
  5. [5] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.